Modern Approaches and Considerations for Designing Real-World Studies
Discover how decentralized study elements, integrated real-world data, and expert analysis plans are redefining modern observational studies.
RWD Data Insights: Linkage of patient services and real-world healthcare data
Explore UBC’s study to see how linking patient support programs and RWD is a source of valuable insights into the patient healthcare journey.
Enriching clinical studies with longitudinal real-world data
Download our case study to explore how UBC linked clinical trial data with six years of pre- and post-trial patient healthcare data, for rich longitudinal real-world evidence development.
Understanding the Natural History of Disease
Learn more about the benefits of natural history studies in drug development.
Gain Strategic Insights by Linking Clinical Trial Data to Real World Data
Read our white paper to explore how integrating RWD/RWE with clinical trial data can overcome challenges and enhance regulatory submissions.
The FDA Expands Confirmatory Evidence: Your Strategy to Expedite Drug Effectiveness Approval
Get the guide to strategic real-world evidence design, integration, and regulatory analytics. Learn how real-world data and natural history studies can expedite your drug’s approval.
Improve Patient Diversity and Expand Access in a Real-World Setting
Boost enrollment in clinical studies that reflects the diversity of the population who will use the medical product.
Planning Real-World Studies to Support Cell and Gene Therapy Evidence Generation Needs
Overcome Cell and Gene Therapy (CGT) study challenges by using strategic real-world data and real-world evidence (RWD/RWE) planning to construct external controls, integrate registries for long-term follow-up (LTFU), and demonstrate product value to regulators and payers.
How to Start Your Real-World Evidence Journey
Figure out how to maximize product value with early, integrated RWE planning.
